Document is current
Any future updates will be listed below
-
Authors
Easwaran, Vigneshwaran
Orayj, Khalid
Goruntla, Narayana
Mekala, Jyothi Suchitra
Bommireddy, Bhavana Reddy
Mopuri, Bhavani
Mantargi, Mohammad Jaffar Sadiq
Bhupalam, Pradeepkumar
Thammisetty, Durga Prasad
Bandaru, Vishnuvandana
-
Funding
Funding for this research was provided by:
Deanship of Research and Graduate Studies, King Khalid University, Large Research Project (RGP2/330/45, RGP2/330/45)
- License Information
-
More Information
Article History
Received: 30 March 2024
Accepted: 30 January 2025
First Online: 11 February 2025
Declarations
:
: The study protocol, data collection tools, and informed consent procedure were approved by the Raghavendra Institute of Pharmaceutical Education Research (RIPER)—Institutional Review Board (RIPER/IRB/PP/2020/053). The study was conducted in accordance with the provisions of the Declaration of Helsinki regarding research with human subjects. All of the eligible participants were approached by a female researcher who could speak the Telugu and English. The researcher explained the study protocol and objectives to the eligible participants and received oral and written consent on a voluntary basis. For illiterate participants, informed consent was obtained from a legally authorized representative or local guardian. The participants were encouraged to share their thoughts and inquiries about the study openly and received clarifications from the principal investigator. All the participants had the complete right to withdraw from the study at any stage of the research process (consent, initiation, process, and completion). The study participants were not subjected to any harm, as the survey was conducted through interviews and did not involve any invasive procedures.
: Not applicable.
: The authors declare no competing interests.
